Chinese Clinical Oncology, Year 2017, Issue 04 -New Issue Alert.


Date: June 04, 2017 at 08:10AM


New Issue TOC Alert

Dear Valued Customer,

We are pleased to deliver your requested table of contents alert for Chinese Clinical Oncology. Year 2017 Issue 04 is now available on CAOD.
In this issue:

The dose and time factors on synergistic effects of the combination of endostar and radiation against hepatic carcinoma xenografts in mice (剂量与时间因素对重组人血管内皮抑素联合放疗抑制小鼠肝癌移植瘤协同作用的影响)
FENG Jundong, ,LUO Wei, ,QIN Shukui, ,WU Qiong, ,WANG Xiaoping, ,YIN Xiaojin, ,SUN Xinchen, ,QU Wenshu, ,YE Qing
…… page:289-297
Effects of miR-138 on cell proliferation and apoptosis of bladder cancer via targeting SIRT1 (miR-138靶向调控SIRT1表达及其对膀胱癌细胞增殖和凋亡的影响)
HUANG Zhuoya, ,MIAO Weixian, ,WANG Xiaobing, ,ZHU Shuling, ,WU Tongtong
…… page:298-302
Analysis of miR-449a/b/c expressions and their clinical significance in non-small cell lung cancer (非小细胞肺癌组织中miR-449a/b/c的表达及临床意义)
HE Wencai, ,JIN Lishan, ,LI Hua
…… page:303-308
The expression of HDAC1, HDAC5, E-cadherin and their correlation in lung adenocarcinoma tissue (肺腺癌组织HDAC1、HDAC5和E-cadherin表达及相关性研究)
SHI Weijiong, ,HAO Jiqing
…… page:309-313
xin xi dong tai (信息动态)

…… page:313
Expression of miRNA-154 in astrocytomas and its clinical significance (miRNA-154在星形细胞瘤中的表达及其临床意义)
DING Jian, ,LI Jilin, ,YU Mingkun
…… page:314-318
An updated meta-analysis of the association between XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk in Chinese population (XRCC1 Arg399Gln基因多态性与中国人群肝细胞癌易感性的Meta分析)
WANG Qian, ,TAN Shiyun
…… page:319-325
Application of improved delta-shaped anastomosis for digestive tract reconstruction in laparoscopic right hemicolectomy of colon cancer (改良三角吻合技术在结肠癌腹腔镜右半结肠切除术后消化道重建中的应用)
SHI Lei, ,LIANG Jianwei, ,ZHOU Haitao, ,WANG Zheng, ,WANG Peng, ,ZHOU Zhixiang
…… page:326-329
Design of normal tissue complication probability(NTCP) and tumor control probability(TCP) calculation program for intensity modulated radiotherapy for nasopharyngeal carcinoma based on EUD (基于EUD鼻咽癌调强放疗中NTCP和TCP的计算程序设计研究)
LU Hong, ,LI Bing, ,SONG Wei, ,YU Dahai, ,ZHAO Di, ,ZHANG Biyun
…… page:330-333
External validation of Halabi nomogram for predicting overall survival of castrate resistant prostate cancer patients (预测去势抵抗性前列腺癌患者总生存期Halabi风险列线图的验证研究)
BIAN Xiaojie, ,SHEN Yijun, ,ZHU Yao, ,YE Dingwei
…… page:334-338
Effect of mediastinoscopic and laparoscopic esophagectomy for early stage and superficial esophageal cancer (纵隔镜联合腹腔镜手术治疗早期及浅表食管癌的效果分析)
HAN Kaibao, ,ZHANG Jianfeng, ,XU Gang, ,LIU Hong, ,WEI Wei, ,WANG Changyong, ,WANG Lele
…… page:339-341
Analysis of influencing factors on sentinel lymph node metastasis in primary breast cancer (原发性乳腺癌前哨淋巴结转移的影响因素分析)
MU Weimin, ,WANG Jing, ,LV Yanli, ,LI Yi
…… page:342-344
Clinical and experimental progression of mesylate apatinib (甲磺酸阿帕替尼的研究现状与进展)
FENG Jiuhuan, ,QIN Shukui, ,WANG Lin
…… page:345-356
Clinical features and management of immune-related events due to immune checkpoint blockades treatment (免疫检测点抑制剂特殊安全性问题的认识及处理)
MA Yuxiang, ,YANG Yunpeng, ,ZHANG Li
…… page:357-361
Progression of cardiotoxicity due to anti-HER-2 medication on patients with HER-2 positive breast cancer (HER-2阳性乳腺癌抗HER-2药物治疗的心脏毒性研究进展)
ZENG Huagui
…… page:362-368
Progress of resistance mechanism of oxaliplatin on hepatocellular carcinoma (奥沙利铂治疗肝细胞癌耐药的相关机制研究进展)
ZHENG Meiling, ,HUA Haiqing
…… page:369-373
Study progress of curculating tumor cell clusers (循环肿瘤细胞团的相关研究进展)
GUO Hailong
…… page:374-378
pa na ti ni zhi liao man xing li xi bao bai xue bing ji lin bian qie t315i tu bian 1 li (帕纳替尼治疗慢性粒细胞白血病急淋变且T315I突变1例)
ZUO Jianguo, ,SHEN Jianzuo, ,ZHANG Langhui, ,FU Haiying, ,ZHOU Huarong, ,ZHANG Zuozuo, ,HUANG Jinlong, ,LIU Wei
…… page:379-381
da la fei ni zhi liao fei xian ai 1 li (达拉非尼治疗肺腺癌1例)
CAO Jie, ,TANG Jinhai
…… page:382-384

CAOD TOC Alerts Note

Thank you for choosing CAOD Table of Contents (TOC) Alert Service.

You are receiving this email because you have requested to receive information from CAOD as a registered user of our Table of Content Alert for journals.
To manage your TOC Alerts, please click here.

For all enquiries, problems or suggestions regarding this service, please contact info.

China/Asia on Demand (CAOD) Customer Service

from Gmail



Εισάγετε τα παρακάτω στοιχεία ή επιλέξτε ένα εικονίδιο για να συνδεθείτε:


Σχολιάζετε χρησιμοποιώντας τον λογαριασμό Αποσύνδεση /  Αλλαγή )

Φωτογραφία Google+

Σχολιάζετε χρησιμοποιώντας τον λογαριασμό Google+. Αποσύνδεση /  Αλλαγή )

Φωτογραφία Twitter

Σχολιάζετε χρησιμοποιώντας τον λογαριασμό Twitter. Αποσύνδεση /  Αλλαγή )

Φωτογραφία Facebook

Σχολιάζετε χρησιμοποιώντας τον λογαριασμό Facebook. Αποσύνδεση /  Αλλαγή )


Σύνδεση με %s